// App-Quantinova.ai

P1040 : HIGHER ESTIMATED PLASMA VOLUME STATUS IS ASSOCIATED WITH INCREASED THROMBOTIC RISK AND IMPAIRED SURVIVAL IN PATIENTS WITH PRIMARY MYELOFIBROSIS

Researchers

Presenter

  • Marko Lucijanic

Principal Investigators

  • Ivan Krecak

  • Davor Galusic

  • Hrvoje Holik

  • Vlatka Perisa

  • Martina Moric Peric

  • Ivan Zekanovic

  • Rajko Kusec

Medical Centers

  • Hematology Department,University hospital center Osijek,Osijek,克罗地亚

  • Internal medicine department,General Hospital Sibenik-Knin county,Sibenik,

  • Hematology Department,University hospital center Osijek,Osijek,克罗地亚

  • Internal medicine Department,General hospital Zadar,Zadar,Croatie

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Internal medicine Department,General hospital Slavonski Brod,Slavo

  • Hematology Department,University hospital center Osijek,Osijek,克罗地亚

  • Internal medicine department,General Hospital Sibenik-Knin county,Sibenik,

  • Internal medicine Department,General hospital Zadar,Zadar,Croatie

  • Hematology Department,University hospital center Split,Split,克罗地亚

  • Internal medicine Department,General hospital Slavonski Brod,Slavo

  • Hematology Department,University hospital center Osijek,Osijek,克罗地亚

  • Internal medicine Department,General hospital Zadar,Zadar,Croatie

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Internal medicine Department,General hospital Zadar,Zadar,Croatie

  • Hematology Department,University hospital center Osijek,Osijek,克罗地亚

  • Hematology Department,University hospital center Osijek,Osijek,克罗地亚

  • Intern

  • Internal medicine Department,General hospital Slavonski Brod,Slavo

  • Internal medicine department,General Hospital Sibenik-Knin county,Sibenik,

  • Hematology Department,University hospital center Osijek,Osijek,克罗地亚

  • Internal medicine Department,General hospital Zadar,Zadar,Croatie

  • Hematology Department,University hospital center Split,Split,克罗地亚

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Rheumatology department, University Hospital Center

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Internal medicine Department,General hospital Slavonski Brod,Slavo

  • Hematology

  • Hematology Department,University hospital center Osijek,Osijek,克罗地亚

  • Hematology Department,University hospital center Osijek,Osijek,克罗地亚

  • Internal medicine Department,General hospital Zadar,Zadar,Croatie

  • Internal medicine Department,General hospital Slavonski Brod,Slavo

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Internal medicine department,General Hospital Sibenik-Knin county,Sibenik,

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Internal medicine department,General Hospital Sibenik-Knin county,Sibenik,

Locations

  • Croatia

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Myelofibrosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A